Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reg reform bill's risk assessment exemption provisions called inadequate by FDA.

This article was originally published in The Tan Sheet

Executive Summary

FDA DEEMS S 343's RISK ASSESSMENT EXEMPTION FOR HEALTH THREATS INADEQUATE to "permit the agency to take expeditious action to avert harm." In an analysis of a revised version of the "Comprehensive Regulatory Reform Act" supported by Senate Majority Leader Robert Dole (R-Kan.) and Sen. Bennett Johnston (D-La.), FDA asserted that the exemption from conducting risk assessments for "likely health and safety threats" would not allow timely FDA actions.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel